- Home
- CMPS vs ELMD Comparison
CMPS vs ELMD Comparison
Compare CMPS & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- ELMD
- Stock Information
- Founded
- CMPS 2020
- ELMD 1992
- Country
- CMPS United Kingdom
- ELMD United States
- Employees
- CMPS N/A
- ELMD N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CMPS Health Care
- ELMD Health Care
- Exchange
- CMPS Nasdaq
- ELMD Nasdaq
- Market Cap
- CMPS 280.2M
- ELMD 251.8M
- IPO Year
- CMPS 2020
- ELMD 2010
- Fundamental
- Price
- CMPS $3.64
- ELMD $34.00
- Analyst Decision
- CMPS Strong Buy
- ELMD
- Analyst Count
- CMPS 6
- ELMD 0
- Target Price
- CMPS $33.60
- ELMD N/A
- AVG Volume (30 Days)
- CMPS 1.1M
- ELMD 92.7K
- Earning Date
- CMPS 02-27-2025
- ELMD 02-11-2025
- Dividend Yield
- CMPS N/A
- ELMD N/A
- EPS Growth
- CMPS N/A
- ELMD 94.54
- EPS
- CMPS N/A
- ELMD 0.72
- Revenue
- CMPS N/A
- ELMD $57,060,000.00
- Revenue This Year
- CMPS N/A
- ELMD $15.95
- Revenue Next Year
- CMPS N/A
- ELMD N/A
- P/E Ratio
- CMPS N/A
- ELMD $47.34
- Revenue Growth
- CMPS N/A
- ELMD 14.73
- 52 Week Low
- CMPS $3.17
- ELMD $9.90
- 52 Week High
- CMPS $12.75
- ELMD $34.99
- Technical
- Relative Strength Index (RSI)
- CMPS 42.17
- ELMD 69.28
- Support Level
- CMPS $3.29
- ELMD $29.39
- Resistance Level
- CMPS $3.62
- ELMD $31.88
- Average True Range (ATR)
- CMPS 0.41
- ELMD 1.51
- MACD
- CMPS -0.03
- ELMD 0.37
- Stochastic Oscillator
- CMPS 23.11
- ELMD 85.63
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.